Literature DB >> 30580078

Diagnostic efficacy of MRI for pre-operative assessment of ovarian malignancy in endometrial carcinoma: A decision tree analysis.

Xiaojuan Xu1, Nan Li2, Yan Chen1, Han Ouyang1, Xinming Zhao1, Jing Zhou3.   

Abstract

AIM: Accurate preoperative assessment of ovarian malignancy in endometrial carcinoma helps in determining the decision to preserve the ovaries in individualized treatment. This study adopted decision tree method to evaluate the diagnostic efficiency of pelvic MRI and clinical data of patients for preoperative identification of endometrial carcinoma-combined ovarian malignancy (EC-OM).
MATERIAL AND METHODS: This retrospective study included a total of 801 patients, and postoperative pathological examinations identified 58 EC-OM group and 743 endometrial carcinoma cases without ovarian malignancy (EC group). Diagnostic efficiency of pelvic MRI in EC-OM was calculated by comparing the clinical data and imaging features of patients in the two groups. Decision tree analysis was performed to screen out associative indexes and establish a diagnostic model for EC-OM.
RESULTS: Pelvic MRI showed that, EC-OM group showed deeper invasion into the myometrium, and higher percentages of patients with cervical or cornual involvement, or metastasis of lymph nodes or peritoneum than EC group (P = 0.00). Preoperative pelvic MRI showed a sensitivity of 51.72% and a specificity of 99.87% when detecting ovarian malignancy in endometrial carcinoma. Decision tree model obtained a sensitivity of 89.66%, with an AUC (area under ROC curve) of 0.949 (95% CI 0.906, 0.993, P < 0.001).
CONCLUSION: Decision tree analysis based on pelvic MRI and clinical data of patients showed that the detection rate of ovarian malignancy could be increased for patients with endometrial carcinoma.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Decision tree; Endometrial carcinoma; Magnetic resonance imaging; Ovarian neoplasms

Mesh:

Year:  2018        PMID: 30580078     DOI: 10.1016/j.mri.2018.12.008

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  3 in total

1.  Application of CT and MRI combined with VEGF-C and EGFR in the identification of endometrial cancer stages.

Authors:  Changsong Li; Jingsheng Yu; Zhexiang Fu
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

2.  Multiparametric magnetic resonance imaging facilitates the selection of patients prior to fertility-sparing management of endometrial cancer.

Authors:  Yuki Himoto; Yulia Lakhman; Shinya Fujii; Satoshi Morita; Jennifer J Mueller; Mario M Leitao; Aki Kido
Journal:  Abdom Radiol (NY)       Date:  2021-04-07

3.  Diagnostic value of 18F-FDG PET/MRI for staging in patients with endometrial cancer.

Authors:  Hideaki Tsuyoshi; Tetsuya Tsujikawa; Shizuka Yamada; Hidehiko Okazawa; Yoshio Yoshida
Journal:  Cancer Imaging       Date:  2020-10-22       Impact factor: 3.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.